YM BioSciences Inc. (Toronto: YM)
Mississauga, Ontario L4W 4Y4, Canada (Map) Phone: 905-6299761
Fax: 905-6294959
http://www.ymbiosciences.com
Overview
The "YM" in BioSciences might stand for "young and modern" as once the letters of YM magazine did. The firm was founded in 1994 to develop a variety of new anti-cancer technologies by licensing potential products already in stages of development. The biotech's drug candidates could help patients with lung, breast, colorectal, brain, head and neck, and other types of cancer. YM BioSciences' pipeline includes nimotuzumab (formerly TheraCIM), a monoclonal antibody therapy designed to enhance the effects of radiation treatment in cancer patients, and AeroLEF, a treatment for moderate to severe pain including cancer pain.
Sample OverviewKey Numbers from Hoover's UK
Key financials for YM BioSciences Inc. (Toronto: YM)
| Company Type | Public (Toronto: YM; NYSE Alternext: YMI) |
|---|---|
| Fiscal Year-End | June |
| 2009 Sales (mil.) | £2.9 |
| 1-Year Sales Growth | (34.0%) |
| 2009 Net Income (mil.) | (£6.8) |
| 2009 Employees | 24 |
| 1-Year Employee Growth | (35.1%) |
Key People from Hoover's UK
Key people and executives for YM BioSciences Inc. (Toronto: YM)
| Chairman and CEO | David G. P. Allan (Subscribers see complete biographies -- view sample)
|
|---|---|
| VP Finance and Administration | Leonard (Len) Vernon |
| VP Corporate Development | Sean Thompson |
Top Competitors from Hoover's UK
Top competitors of YM BioSciences Inc. (Toronto: YM)
There are 11 competitors for YM BioSciences; see more.Industry Information from Hoover's UK
First Research Industry Profiles Extensive Industry Intelligence
Hoover's Industries
More Industry InformationSubsidiaries/Affiliates Covered By Hoover's UK
Subsidiaries/affiliates of YM BioSciences Inc. (Toronto: YM)
